NeoGenomics Expands Investor Relations Program
Thursday May 25, 1:59 pm ET
Cancer Genetic Testing Company Selects Hawk Associates for Additional Services
FORT MYERS, Fla., May 25 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM - News) a high-complexity CLIA-certified clinical laboratory that offers cancer genetic diagnostic testing services nationwide, announced today that it has increased the scope of its investor relations program with Hawk Associates. Beginning today, NeoGenomics will be featured for investor awareness and information on the Hawk Associates website, hawkassociates.com , in addition to the American Microcap Institute website, americanmicrocaps.com .
Hawk Associates will provide additional services for the company, including a virtual investor relations kit, e-mail alerts about news from the company, regular company profile updates, assistance with quarterly conference calls, and press release support. Hawk will also handle investor queries for the company.
Frank Hawkins, CEO of Hawk Associates, said, "We are pleased that NeoGenomics has expanded its investor relations program. The company recently reported its first profitable quarterly results and has completed an accretive acquisition of a lab centrally located in Nashville, TN. We look forward to working closely with this energetic young company to help tell its story to investors."
Robert Gasparini, president of NeoGenomics, said, "We have grown to the point where it is important to have a full-service investor relations firm available to help us communicate effectively with our shareholders while the management team concentrates on executing our strategy for growth. Hawk Associates has done an excellent job in articulating the investment thesis for NeoGenomics through their 37 page in-depth equity research report, which they published through their American Microcap Institute subsidiary. We plan to build upon this effort through the state-of-the-art Hawk website that also offers a virtual investor kit for 24/7 access by investors. We encourage investors to take advantage of Hawk's e-mail alert system."
Information for investors, including a profile of NeoGenomics and the subscription form for free NeoGenomics e-mail alert notifications can be obtained by visiting hawkassociates.com or americanmicrocaps.com . Interested parties can also access an in- depth equity research report from the American Microcap Institute at americanmicrocapinstitute.com .
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that offers cancer genetic diagnostic testing services including cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry and molecular genetic testing. NeoGenomics is headquartered in Fort Myers, Fla., and services the needs of oncologists, pathologists, urologists, hospitals and other reference laboratories not offering genetic testing throughout the United States. For additional information about NeoGenomics, visit neogenomics.org .
An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at hawkassociates.com and americanmicrocaps.com. For investor relations questions regarding NeoGenomics, contact Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info@hawkassociates.com . |
